Article info
Neurogenetics
Original research
Plasma NfL levels and longitudinal change rates in C9orf72 and GRN-associated diseases: from tailored references to clinical applications
- Correspondence to Dr Isabelle Le Ber, Sorbonne Université, Paris Brain Institute–Institut du Cerveau (ICM), Inserm U1127, CNRS UMR 7225; Reference Centre for Rare or Early Dementias, IM2A, Département de Neurologie, Hopital Universitaire Pitie Salpetriere, Paris, France; isabelle.leber{at}upmc.fr
Citation
Plasma NfL levels and longitudinal change rates in C9orf72 and GRN-associated diseases: from tailored references to clinical applications
Publication history
- Received April 19, 2021
- Accepted July 13, 2021
- First published August 4, 2021.
Online issue publication
January 07, 2022
Supplementary Data
This web only file has been produced by the BMJ Publishing Group from an electronic file supplied by the author(s) and has not been edited for content.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
© Author(s) (or their employer(s)) 2021. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. http://creativecommons.org/licenses/by-nc/4.0/This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/.